Online citations, reference lists, and bibliographies.
← Back to Search

L-735,524: An Orally Bioavailable Human Immunodeficiency Virus Type 1 Protease Inhibitor.

J. Vacca, B. Dorsey, W. Schleif, R. B. Levin, S. L. Mcdaniel, P. Darke, J. Zugay, J. Quintero, O. M. Blahy, E. Roth
Published 1994 · Biology, Medicine

Save to my Library
Download PDF
Analyze on Scholarcy Visualize in Litmaps
Reduce the time it takes to create your bibliography by a factor of 10 by using the world’s favourite reference manager
Time to take this seriously.
Get Citationsy
To date, numerous inhibitors of the human immunodeficiency virus type 1 protease have been reported, but few have been studied extensively in humans, primarily as a consequence of poor oral bioavailability in animal models. L-735,524 represents a class of human immunodeficiency virus type 1 protease inhibitors, termed hydroxyaminopentane amides, that incorporate a basic amine into the hydroxyethylene inhibitor backbone. L-735,524 is a potent inhibitor of virus replication in cell culture and inhibits the protease-mediated cleavage of the viral precursor polyproteins that results in the production of noninfectious progeny viral particles. The compound is effective against viruses resistant to reverse transcriptase inhibitors and is synergistically active when used in combination with reverse transcriptase inhibitors. Most importantly, L-735,524 exhibits good oral bioavailability and plasma pharmacokinetic profiles in two species of laboratory animals by using clinically acceptable formulations. Accordingly, the compound was selected for evaluation of safety and pharmacokinetic studies in humans.

This paper is referenced by
Chemoenzymatic Synthesis of Pharmacologically Active Compounds Containing Chiral 1,2‐Amino Alcohol Moiety
Pankaj Gupta (2021)
1,3‐Diazepine: A privileged scaffold in medicinal chemistry
Yohan Malki (2021)
Chiron approach and the [4 + 2] Diels-Alder cycloaddition of 2-pyrones for the synthesis of cis-(-)-aminoindan-2-ol
Arturo de la Rosa-Barrales (2021)
Enzymes as Drug Targets
T. Meek (2021)
Principles and applications of small molecule peptidomimetics
A. Trabocchi (2020)
Regio‐ and Diastereoselective Rhodium‐Catalyzed Allylic Substitution with Unstabilized Benzyl Nucleophiles
Debasis Pal (2020)
Synthesis and characterization of piperazine-substituted dihydrofuran derivatives viaMn(OAc) 3 mediated radical cyclizations
Sait Sari (2020)
Asymmetric Ring-Opening of Epoxides Catalyzed by Metal–Salen Complexes
Anna Lidskog (2020)
Regio- and Diastereoselective Rhodium-Catalyzed Allylic Substitution with Unstabilized Benzyl Nucleophiles.
Debasis Pal (2020)
Concise, gram-scale synthesis of furo[2,3-b]pyridines with functional handles for chemoselective cross-coupling.
Sean N O'Byrne (2020)
Protease Inhibitors for the Treatment of HIV/AIDS: Recent Advances and Future Challenges.
Chandrashekhar Voshavar (2019)
Dinuclear zinc synergistic catalytic asymmetric phospha-Michael/Michael cascade reaction: synthesis of 1,2,3-trisubstituted indanes bearing phosphoryl groups.
Bing-Kai Tao (2019)
A Structural View on Medicinal Chemistry Strategies against Drug Resistance.
S. Agnello (2019)
Synthesis and characterization of unsaturated diacyl and alkyl-acyl piperazinederivatives
Sait Sari (2019)
Chemical Intuition in Drug Design and Discovery.
Júlia G. B. Pedreira (2019)
Eine strukturelle Evaluierung medizinalchemischer Strategien gegen Wirkstoffresistenzen
Stefano Agnello (2019)
Organocatalytic Asymmetric Cascade Reaction of γ‐Substituted Deconjugated Butenolides with o‐Formyl‐β‐nitrostyrene
Siddharth K Deepake (2018)
Biocatalytic approaches towards the stereoselective synthesis of vicinal amino alcohols
Pankaj Gupta (2018)
Rational CCL5 mutagenesis integration in a lactobacilli platform generates extremely potent HIV-1 blockers
M. Secchi (2018)
Development and Evaluation of Peptide-Functionalized Gold Nanoparticles for HIV Integrase Inhibition
Lavanya Singh (2018)
Mechanistic enzymology in drug discovery: a fresh perspective
G. Holdgate (2018)
Catalytic enantioselective synthesis of α-chiral azides
Pei-Gang Ding (2018)
An Efficient One‐Pot Synthesis of Chiral N‐Protected 3‐Substituted (Diketo)piperazines via Ugi‐4CR/De‐Boc/Cyclization Process
M. Jida (2018)
Nature Inspired Molecular Design: Stereoselective Synthesis of Bicyclic and Polycyclic Ethers for Potent HIV-1 Protease Inhibitors.
A. Ghosh (2018)
6-(2-Fluorobenzoyl)-3-(2-(4-(4-fluorophenyl)piperazin-1-yl)-2-oxoethyl)benzo[d]thiazol-2(3H)-one drug molecule structure and its interaction with atmospheric pressure plasma jet
M. Tanışlı (2017)
General Procedures for the Lithiation/Trapping of N-Boc Piperazines.
James D. Firth (2017)
HIV protease inhibitor resistance
A. Wensing (2017)
Investigation of the binding free energies of FDA approved drugs against subtype B and C-SA HIV PR: ONIOM approach.
Z. K. Sanusi (2017)
Sexual behaviour of HIV-diagnosed men who have sex with men in England in the era of effective antiretroviral therapy: results from the ASTRA study
M. Daskalopoulou (2017)
Studies on HIV-1 Protease and its Inhibitors
S. Dubey (2017)
Switchable Chemoselectivity for Organocatalytic, Asymmetric Malononitrile Addition to ortho-Formyl Chalcones.
Sanjay Maity (2017)
Visible-Light-Induced Tandem Radical Addition-Cyclization of Alkenyl Aldehydes Leading to Indanones and Related Compounds.
Danyang Lu (2017)
See more
Semantic Scholar Logo Some data provided by SemanticScholar